Home | Welcome to Contract Pharma   
Last Updated Monday, May 20 2013
Print RSS Feed

Breaking News

Related Searches: Promotions & Moves •
Pozen

September 14, 2009
Elizabeth A. Cermak has been named executive vice president, chief commercial officer of Pozen, Inc.  Read More »
Goodwin Completes Areva Conjugate Mfg.

September 14, 2009
Goodwin Biotechnology Inc. has completed the cGMP manufacturing and vialing of Areva Med's MAb-chelator conjugate  Read More »
QPharma Opens Specialized Pharmacy, QPharmaRx

September 11, 2009
QPharma, Inc., has opened its Specialized Pharmacy, QPharmaRx. The company currently manages fulfillment programs for clients that engage in Patient Assistance Programs that target both patients and practitioners.  Read More »
Amylin, Biocon Enter Global R&D Pact

September 11, 2009
Amylin Pharmaceuticals and Biocon, Ltd. have entered into an exclusive agreement to develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes.  Read More »
Complete Response Letter for Centocor’s Doxil

September 11, 2009
J&J unit Centocor Ortho Biotech Products received a Complete Response letter from the FDA regarding its sNDA for Doxil (doxorubicin HCI liposome injection) in combination with docetaxel for the treatment of metastatic breast cancer.  Read More »
Millennium Starts Phase II Prostate Cancer Trial

September 11, 2009
Takeda Pharmaceutical Co. Ltd. and its wholly-owned subsidiary Millennium, The Takeda Oncology Co., initiated a Phase II trial of TAK-700 in patients with advanced prostate cancer.  Read More »
Lonza Breaks Ground in Singapore

September 10, 2009
Lonza Group broke ground at Tuas Biomedical Park in Singapore for the new facility for its Cell Therapy business.   Read More »
Merck Drops One Migraine Program, Continues Another

September 10, 2009
Merck has updated the status of the clinical development programs for MK-0974 (telcagepant) and MK-3207, the company's investigational oral calcitonin gene-related peptide (CGRP) receptor antagonists for the treatment of acute migraine.  Read More »
Quintiles Adds Pretoria U. to Prime Site Program

September 10, 2009
Quintiles has entered a strategic alliance agreement with the University of Pretoria as part of its Prime Site program, an initiative to accelerate the development of new and more effective medicines.  Read More »
Evotec, Biogen Enter Research Pact

September 9, 2009
Evotec AG has entered into a research agreement with Biogen Idec, under which Evotec will use its protein production technologies, assay development and high throughput screening to identify hit molecules for Biogen.  Read More »
Advion BioServices Expands Biomarker Group

September 9, 2009
Advion BioServices, Inc. has expanded its LC/MS Biomarker Services Group in response to increased interest in the use of biomarkers in drug development.  Read More »
Helsinn Group

September 9, 2009
William Mann, Ph.D., has been appointed chief executive officer for Helsinn Group’s American subsidiary, Helsinn Therapeutics (U.S.) Inc.   Read More »
Laureate To Make MAb for Neoprobe

September 8, 2009
Neoprobe and Laureate Pharma have entered into a Biopharmaceutical Development and Manufacturing Agreement  Read More »
Bayer Schering IND Filing Triggers Milestones

September 8, 2009
Bayer Schering Pharma AG has filed to initiate a Phase I trial of MN-IC, an antibody-drug conjugate (ADC) for oncology  Read More »
Roche

September 8, 2009
Pascal Soriot has been named chief operating officer of Roche's Pharma Division  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: